Chipmaker Qualcomm is reportedly talking to GlaxoSmithKline about setting up a $1 billion joint venture. The deal, reports of which were posted by two financial publications, would mark a continuation of Qualcomm's drive to tighten its ties to biopharma, which was given impetus last year when it set up a VC fund with Novartis and inked a deal with Roche.
The joint venture set up by Novartis and Qualcomm has teamed up with Lux Capital to funnel $6.5 million into Science 37. Los Angeles, CA-based Science 37 will use the cash to step up the expansion of its virtual, tech-enabled model of clinical trial services. Read more >>
POPULAR COMMENT THREADS
Big Pharma consortium TransCelerate BioPharma has released a portal through which research sites can interact with multiple clinical trial sponsors. The portal is intended to free clinical trial sites from the duplicated workload and administrative burdens associated with using a different portal for each of the sponsors with which they work.
GlaxoSmithKline has gained an ally in its push to accelerate drug discovery by collaborating on the application of computational biology to target validation. The ally, Biogen, is the first firm to join the initiative since GSK set it up in collaboration with the Wellcome Trust Sanger Institute and the European Bioinformatics Institute in 2014.
Genomics England has signed up Illumina and Icon to support the 100,000 Genomes Project. Illumina, which has been closely involved with Genomics England since the start, is working to develop informatics tools, while CRO Icon is taking responsibility for managing data generated in the sequencing program.
After teething problems, Eli Lilly hails success of transition of 15,000 staff from laptops to iPads
Eli Lilly is hailing its move from laptops to Apple's iPad as a success. Having committed to the transition several years ago, Lilly now has 15,000 iPad-equipped staffers and is in the process of upgrading to the Pro model, but getting to this point has caused some headaches for the company.
Celgene has expanded its deal with Medidata. Having primarily tapped Medidata for its Rave electronic data capture system over the course of their 8-year relationship, Celgene has now secured itself access to a handful of other pieces of software.
The team behind a planned 10,000-person, 265,000-square-meter cancer research and care hub in London is looking for software developers to occupy some of the site. By housing software companies, biotechs, med-tech developers and other companies in part of the U.K.'s cancer research and care network, the team is aiming to better connect the public and private sectors.
From Our Sister Sites
Pfizer Consumer Healthcare announced the launch of joint health and wellness innovation program that will enable 10 med tech startups to utilize the San Francisco office of tech industry incubator Galvanize.
India's Sun Pharmaceutical saw its sales in the U.S., its largest market, continue to fall as problems with a key plant in India have yet to be resolved. U.S. sales were off 11% to $486 million in the quarter ended Dec. 31, 2015, India's largest drugmaker reported today.